BMS-919373

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

Acute Coronary SyndromesAtrial FibrillationParoxysmal Atrial Fibrillation

Phase 1

Drug Interaction Statin

CompletedNCT02089061

Bristol-Myers SquibbAcute Coronary Syndromes

Start: 2014-03-31End: 2014-05-31Updated: 2014-08-15

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

TerminatedNCT02153437

Bristol-Myers SquibbAtrial Fibrillation

Start: 2014-10-30End: 2016-10-20Updated: 2023-12-19

Phase 2

A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation

TerminatedNCT02156076

Bristol-Myers SquibbParoxysmal Atrial Fibrillation

Start: 2014-07-25End: 2016-06-01Updated: 2019-07-31